Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,798 public trials 656 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Active, not recruiting

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

NCT07105488

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Mountain West Derm - Blackhart PLLC dba Skin Cancer and Dermatology Institute Phoenix, Arizona, United States
  • Skin Cancer and Dermatology Institute Phoenix, Arizona, United States
  • T. Joseph Raoof Md, Inc Encino, California, United States
  • Marvel Clinical Research Huntington Beach, California, United States
View all 88 locations
View Trial Details
Active, not recruiting

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

NCT06052267

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 15706 Birmingham, Alabama, United States
  • Teva Investigational Site 15786 Birmingham, Alabama, United States
  • Teva Investigational Site 15768 Dothan, Alabama, United States
  • Teva Investigational Site 15581 Paradise Valley, Arizona, United States
View all 393 locations
View Trial Details
Active, not recruiting

A Study Evaluating APG777 in Atopic Dermatitis

NCT06395948

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Fountain Valley, California, United States
  • Investigational Site Los Angeles, California, United States
  • Investigational Site San Diego, California, United States
  • Investigational Site New Haven, Connecticut, United States
View all 94 locations
View Trial Details
Active, not recruiting

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

NCT06931405

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, +13 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Acuro Research, Inc. Little Rock, Arkansas, United States
  • Modena Allergy & Asthma Clinical Research - La Jolla La Jolla, California, United States
  • Allergy & Asthma Associates of Southern California Laguna Niguel, California, United States
View all 47 locations
View Trial Details
Active, not recruiting

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

NCT05677451

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Kern Research Bakersfield, California, United States
  • Allergy and Asthma Medical Group and Research Center San Diego, California, United States
  • Pediatric Dermatology of Miami at the Pediatric CoE Miami, Florida, United States
  • Treasure Valley Medical Research Boise, Idaho, United States
View all 50 locations
View Trial Details
Active, not recruiting

A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65

NCT07060885

Conditions
Allergic Rhinitis, Allergic Rhinoconjunctivitis, Hypersensitivity, +8 more
Locations
  • Beijing Tongren Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Fujian Provincial Hospital Fuzhou, Fujian, China
  • The first hospital affiliated Fujian medical University Fuzhou, Fujian, China
  • The first affiliated hospital of guangzhou medical university-respiratory department Guangzhou, Guangdong, China
View all 30 locations
View Trial Details
Active, not recruiting

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma

NCT05692180

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • Research Site Torrance, California, United States
  • Research Site Ocala, Florida, United States
  • Research Site Owensboro, Kentucky, United States
  • Research Site Lafayette, Louisiana, United States
View all 43 locations
View Trial Details

Related conditions